The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

After assuming the charges of portfolios on Friday, the Health and Transport Minister Dr Pankaj Singh on Friday said a probe ...

Investors were in a sell-the-news mood this week. Just the whiff of bad news sent many stocks sharply lower. And, as you’ll see, the MarketBeat analysts were quick to dissect the news and how it ...

Delhi's new BJP-led administration announced a significant healthcare reform strategy, addressing staffing shortages, ...

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

Stock futures rise as traders eye Fed minutes and tariffs. Tesla, Intel, and Buffett-backed Constellation lead pre-market ...

Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announces the third positive safety review by the independent Data and Safety Monitoring Board for its Casppian Phase 3 registration study. The ...

ImmunityBio, Inc. , a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital alternative ...